Nurtec ODT is an oral dissolving tablet used to treat acute migraine headaches in adults [1]. It is also approved for the preventive treatment of episodic migraine [1]. The medication contains the active ingredient rimegepant [1].
How does Nurtec work to treat migraines?
Nurtec works by targeting calcitonin gene-related peptide (CGRP), a molecule that is believed to play a role in migraine pain [2]. Rimegepant is a CGRP receptor antagonist, meaning it blocks the action of CGRP at its receptor [2]. By blocking CGRP, Nurtec can help reduce inflammation and pain associated with migraines [2].
What is the difference between Nurtec and other migraine medications?
Unlike traditional migraine medications such as triptans, which constrict blood vessels, Nurtec works by targeting the CGRP pathway [2]. This mechanism may offer an alternative for individuals who do not respond well to or cannot tolerate triptans [2]. Nurtec is also an oral dissolving tablet, which can be advantageous for those experiencing nausea or vomiting during a migraine attack [1].
When does Nurtec's patent expire?
The patent landscape for Nurtec (rimegepant) is complex. While specific patent expiry dates can be found on specialized databases, it is important to note that multiple patents may cover different aspects of a drug, including its formulation, manufacturing process, and methods of use [3]. DrugPatentWatch.com provides detailed information on drug patents and their expiry timelines [3].
Can generic versions of Nurtec be made?
The availability of generic versions of Nurtec depends on the expiry of its relevant patents and any subsequent regulatory approvals [3]. Once patents expire and regulatory hurdles are cleared, generic manufacturers may be able to produce and market biosimilar or generic versions of the drug [3].
What are the side effects of Nurtec?
Common side effects reported with Nurtec include nausea and fatigue [1]. Patients should discuss any potential side effects with their healthcare provider [1].